ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,416Medicare Part D Prescriptions Filled, Including Refills

Rank: 389 out of 2094

$541K Total Retail Price of All Prescriptions

Rank: 431 out of 2094

416 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
72% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 416 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

2% of this provider’s 6,321 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$73 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
AMLODIPINE BESYLATE 298 276 1 2
SIMVASTATIN 202 178 2 1
LEVOTHYROXINE SODIUM 181 181 3 3
OMEPRAZOLE 180 140 4 4
METOPROLOL TARTRATE 167 150 5 10
FUROSEMIDE 165 148 6 6
GABAPENTIN 159 116 7 23
NEXIUM 147 129 8 16
TRAMADOL HCL 146 116 9 33
WARFARIN SODIUM 139 137 10 11
LISINOPRIL 129 96 11 7
CITALOPRAM HBR 111 99 12 47
CLOPIDOGREL 102 94 13 22
CRESTOR 94 90 14 15
ATORVASTATIN CALCIUM 87 72 15 5
POTASSIUM CHLORIDE 82 82 16 24
PLAVIX 80 71 17 38
SERTRALINE HCL 77 70 18 26
METFORMIN HCL 72 60 19 8
CARVEDILOL 69 67 20 19
OXYCODONE-ACETAMINOPHEN 68 63 S2 21 40
CLOTRIMAZOLE-BETAMETHASONE 64 58 22 91
PRAVASTATIN SODIUM 63 53 23 18
CIPROFLOXACIN HCL 63 53 23 81
ESCITALOPRAM OXALATE 62 52 25 46
AZITHROMYCIN 62 44 25 27
ADVAIR DISKUS 59 56 27 36
RAMIPRIL 57 56 28 48
PANTOPRAZOLE SODIUM 56 54 29 37
MIRTAZAPINE 55 53 30 43
ALENDRONATE SODIUM 52 52 31 30
DIOVAN 50 47 32 13
CELEBREX 50 50 32 74
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 10, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.